{"id":"https://openalex.org/W2292007328","doi":"https://doi.org/10.1002/ejhf.452","title":"Response to: Hyperkalaemia in Heart Failure: Binding the Patient to Improved Treatment?","display_name":"Response to: Hyperkalaemia in Heart Failure: Binding the Patient to Improved Treatment?","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2292007328","doi":"https://doi.org/10.1002/ejhf.452","mag":"2292007328","pmid":"https://pubmed.ncbi.nlm.nih.gov/26634417","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5063125"},"language":"en","primary_location":{"id":"doi:10.1002/ejhf.452","doi":"https://doi.org/10.1002/ejhf.452","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ejhf.452","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejhf.452","source":{"id":"https://openalex.org/S87609158","display_name":"European Journal of Heart Failure","issn_l":"1388-9842","issn":["1388-9842","1879-0844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Heart Failure","raw_type":"journal-article"},"volume":null,"type":"letter","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejhf.452","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042843111","display_name":"Bertram Pitt","orcid":"https://orcid.org/0000-0001-5880-275X","observed_orcids":["https://orcid.org/0000-0001-5880-275X","https://orcid.org/0000-0001-7703-0345"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bertram Pitt","raw_affiliation_strings":["Department of Medicine, University of Michigan School of Medicine , 1500 East Medical Center Drive, Ann Arbor, MI, 48109-0366 ,","Department of Medicine, University of Michigan School of Medicine, 1500 East Medical Center Drive, Ann Arbor, MI, 48109-0366 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Michigan School of Medicine , 1500 East Medical Center Drive, Ann Arbor, MI, 48109-0366 ,","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]},{"raw_affiliation_string":"Department of Medicine, University of Michigan School of Medicine, 1500 East Medical Center Drive, Ann Arbor, MI, 48109-0366 USA","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033996338","display_name":"Matthew R. Weir","orcid":"https://orcid.org/0000-0001-8820-5702","observed_orcids":["https://orcid.org/0000-0001-8820-5702"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew R. Weir","raw_affiliation_strings":["Nephrology Division, University of Maryland School of Medicine , Baltimore, MD ,","Nephrology Division, University of Maryland School of Medicine, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nephrology Division, University of Maryland School of Medicine , Baltimore, MD ,","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"Nephrology Division, University of Maryland School of Medicine, Baltimore, MD, USA","institution_ids":["https://openalex.org/I126744593"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5042843111"],"corresponding_institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"],"apc_list":{"value":5300,"currency":"USD","value_usd":5300},"apc_paid":{"value":5300,"currency":"USD","value_usd":5300},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"2","first_page":"216","last_page":"216"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperkalemia","display_name":"hyperkalemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.9929999709129333},{"id":"https://openalex.org/keywords/potassium-binding-agents","display_name":"potassium-binding agents","score":0.7870000004768372},{"id":"https://openalex.org/keywords/patiromer","display_name":"patiromer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/renin-angiotensin-aldosterone-system-inhibitors","display_name":"renin-angiotensin-aldosterone system inhibitors","score":0.949999988079071},{"id":"https://openalex.org/keywords/mortality-risk","display_name":"mortality risk","score":0.5730000138282776},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.6579999923706055},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.5040000081062317},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7360152006149292},{"id":"https://openalex.org/C2780243291","wikidata":"https://www.wikidata.org/wiki/Q605259","display_name":"Hyperkalemia","level":2,"score":0.7198346853256226},{"id":"https://openalex.org/C517785266","wikidata":"https://www.wikidata.org/wiki/Q703","display_name":"Potassium","level":2,"score":0.6906660795211792},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.6056200265884399},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.5753107666969299},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5273733139038086},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5180928111076355},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47002172470092773},{"id":"https://openalex.org/C2778525890","wikidata":"https://www.wikidata.org/wiki/Q184564","display_name":"Aldosterone","level":2,"score":0.44953328371047974},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.39814361929893494},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3421393036842346},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.13132774829864502},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006947","descriptor_name":"Hyperkalemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011188","descriptor_name":"Potassium","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1002/ejhf.452","doi":"https://doi.org/10.1002/ejhf.452","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ejhf.452","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejhf.452","source":{"id":"https://openalex.org/S87609158","display_name":"European Journal of Heart Failure","issn_l":"1388-9842","issn":["1388-9842","1879-0844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Heart Failure","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5063125","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5063125","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur J Heart Fail","raw_type":"Text"},{"id":"pmid:26634417","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26634417","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of heart failure","raw_type":"Letter"},{"id":"pmh:oai:deepblue.lib.umich.edu:2027.42/134168","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2027.42/134168","pdf_url":"https://hdl.handle.net/2027.42/134168","source":{"id":"https://openalex.org/S4306400393","display_name":"Deep Blue (University of Michigan)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I27837315","host_organization_name":"University of Michigan","host_organization_lineage":["https://openalex.org/I27837315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1002/ejhf.452","doi":"https://doi.org/10.1002/ejhf.452","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ejhf.452","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejhf.452","source":{"id":"https://openalex.org/S87609158","display_name":"European Journal of Heart Failure","issn_l":"1388-9842","issn":["1388-9842","1879-0844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Heart Failure","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2351744653","display_name":null,"funder_award_id":"48109","funder_id":"https://openalex.org/F4320309652","funder_display_name":"University of Michigan"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307771","display_name":"Bayer","ror":"https://ror.org/04hmn8g73"},{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309652","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291"},{"id":"https://openalex.org/F4320310174","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305"},{"id":"https://openalex.org/F4320310567","display_name":"Boston Scientific Corporation","ror":"https://ror.org/0385es521"},{"id":"https://openalex.org/F4320330753","display_name":"Akebia Therapeutics","ror":"https://ror.org/003br8b23"},{"id":"https://openalex.org/F4320332460","display_name":"College of Pharmacy, University of Michigan","ror":"https://ror.org/00jmfr291"},{"id":"https://openalex.org/F4320336263","display_name":"Relypsa","ror":"https://ror.org/05japc090"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2292007328.pdf","grobid_xml":"https://content.openalex.org/works/W2292007328.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W2102345072","https://openalex.org/W2152271789","https://openalex.org/W2163340573","https://openalex.org/W2324948948"],"related_works":["https://openalex.org/W2163340573","https://openalex.org/W2762183561","https://openalex.org/W2744054695","https://openalex.org/W2910195364","https://openalex.org/W2217407415","https://openalex.org/W4283360316","https://openalex.org/W2765837691","https://openalex.org/W4282963834","https://openalex.org/W3090042183","https://openalex.org/W4296394050"],"abstract_inverted_index":{"We":[0,103,300,315],"appreciate":[1],"the":[2,67,113,118,130,135,195,325,336,350,358],"insightful":[3],"and":[4,24,97,253,335,353,363,366,414,417,424,437,441,455,482],"balanced":[5],"Editorial1":[6],"by":[7,383],"Dr":[8,320],"Konstam":[9],"regarding":[10],"our":[11],"study.2":[12],"However,":[13],"we":[14],"wish":[15],"to":[16,39,80,106,145,148,155,169,188,310,348],"take":[17,349],"issue":[18],"with":[19,236,269,306,319,376],"one":[20],"of":[21,76,83,117,172,175,200,212,251,273,281,293,327,343,360,388,392],"his":[22],"statements":[23],"its":[25],"implications.":[26],"The":[27],"Editorial":[28,379],"states,":[29],"\u201cOver":[30],"4":[31],"weeks,":[32],"in":[33,78,110,160,234,284,374],"each":[34],"trial,":[35],"patients":[36,91,120,235,283,305,375],"were":[37,121,152,183],"allowed":[38,154],"have":[40,256],"serum":[41,141,158,190,213,263,296],"potassium":[42,95,142,159,191,214,264,297],"levels":[43,61,82,96,211,217],"as":[44,46,64,66,92,94,218,220,238],"high":[45],"6.2":[47],"mmol/L":[48,52,193,222,266],"(HARMONIZE)":[49],"or":[50,133,178,215],"6.5":[51],"(OPAL-HK)":[53],"without":[54,62,227,312],"intervention":[55],"and,":[56],"apparently,":[57],"they":[58],"tolerated":[59,226],"these":[60,210,328,361],"difficulty,\u201d":[63],"well":[65],"follow-up":[68],"statement,":[69],"\u201cThese":[70],"findings":[71],"strongly":[72],"suggest":[73,208],"that":[74,109,127,209,233],"down-titration":[75],"RAASi":[77],"response":[79],"lower":[81],"hyperkalaemia":[84,309],"may":[85],"be":[86,146,224],"unnecessarily":[87],"conservative":[88],"for":[89,339,449],"most":[90],"long":[93],"kidney":[98,240],"function":[99],"are":[100],"carefully":[101],"monitored.\u201d1":[102],"would":[104,301],"like":[105],"point":[107],"out":[108],"OPAL-HK,3":[111],"during":[112,163,194],"first":[114],"3":[115],"weeks":[116],"study,":[119],"treated":[122],"using":[123],"a":[124,157,164,189,259,262,279,295,355,444],"dosing":[125],"algorithm":[126],"required":[128],"increasing":[129,231],"patiromer":[131,177],"dose":[132,173],"discontinuing":[134],"renin-angiotensin-aldosterone":[136],"system":[137],"inhibitor":[138],"(RAASi)":[139],"if":[140],"was":[143,288,381],"observed":[144],"5.5":[147],"<6.5":[149],"mmol/L.":[150],"Patients":[151],"only":[153],"maintain":[156],"this":[161,201,205],"range":[162],"relatively":[165,202],"short":[166],"period":[167],"(up":[168],"\u223c9":[170],"days)":[171],"adjustment":[174],"either":[176],"their":[179],"RAASi.3":[180],"While":[181],"there":[182],"no":[184],"apparent":[185],"deaths":[186],"related":[187],"\u22655.5":[192,298],"initial":[196],"4-week":[197],"treatment":[198],"phase":[199],"small":[203],"study,2":[204],"does":[206],"not":[207],"even":[216,307],"low":[219],"5.1":[221],"can":[223],"safely":[225],"intervention.":[228,314],"There":[229],"is":[230,267,278,346,442],"evidence":[232],"comorbidities\u2014such":[237],"chronic":[239],"disease,":[241],"heart":[242,377],"failure,":[243],"and/or":[244],"diabetes":[245],"mellitus\u2014especially":[246],"those":[247,254],"over":[248],"65":[249],"years":[250],"age":[252],"who":[255],"recently":[257],"experienced":[258],"myocardial":[260],"infarction,":[261],">5.0":[265],"associated":[268],"an":[270],"increased":[271,286],"risk":[272],"death.4":[274],"Of":[275],"particular":[276],"importance":[277],"study":[280],"VA":[282],"which":[285],"mortality":[287,367],"found":[289],"within":[290],"1":[291],"day":[292],"observing":[294],"mmol/L.5":[299],"caution":[302],"against":[303],"allowing":[304],"mild":[308],"remain":[311],"appropriate":[313],"would,":[316],"however,":[317],"agree":[318],"Konstam's":[321],"statement":[322],"that,":[323],"\u201cWith":[324],"availability":[326],"newer,":[329],"safer,":[330],"more":[331],"tolerable":[332],"potassium-binding":[333],"agents":[334,362],"demonstrated":[337],"potential":[338],"retaining":[340],"higher":[341],"doses":[342],"RAASi,":[344],"it":[345],"important":[347],"next":[351],"step":[352],"explore":[354],"connection":[356],"between":[357],"pharmacodynamics":[359],"reduced":[364],"morbidity":[365],"through":[368],"well-designed,":[369],"prospective":[370],"randomized":[371],"clinical":[372],"trials":[373],"failure.\u201d1":[378],"assistance":[380],"provided":[382],"Brian":[384],"J.":[385],"Catton,":[386],"PharmD,":[387],"AlphaBioCom,":[389],"LLC.":[390],"Conflicts":[391],"interest:":[393],"B.P.":[394],"reports":[395,421],"consulting":[396,422,461],"fees":[397,423,462],"from":[398,427,463],"Pfizer,":[399],"Inc.;":[400,407,410,429,434,436,466,480],"Bayer":[401],"AG;":[402,451],"AstraZeneca":[403],"plc;":[404],"Stealth":[405],"Biotherapeutics,":[406],"Sarfez":[408],"Pharmaceuticals,":[409],"Merck;":[411],"SD":[412],"Pharmaceuticals;":[413,474],"Eli":[415],"Lilly":[416],"Company.":[418],"He":[419],"also":[420],"holds":[425],"stock":[426],"Relypsa,":[428,479],"AuraSense":[430],"Therapeutics;":[431],"PharmaIN;":[432],"Tricida,":[433],"scPharmaceuticals,":[435],"DaVinci":[438],"BioSciences,":[439],"LLC;":[440],"on":[443],"Data":[445],"Safety":[446],"Monitoring":[447],"Board":[448],"Novartis":[450],"Johnson":[452],"&":[453,477],"Johnson;":[454],"Oxygen":[456],"Biotherapeutics.":[457],"M.R.W.":[458],"has":[459],"received":[460],"Akebia":[464],"Therapeutics,":[465],"Amgen;":[467],"Astra;":[468],"Boston":[469],"Scientific;":[470],"Janssen":[471],"Pharmaceutica;":[472],"Lexicon":[473],"Merck":[475],"Sharp":[476],"Dohme;":[478],"Sandoz;":[481],"Sanofi.":[483]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}